The company has 21 facilities in Arkansas, Mississippi and Tennessee and plans to use the $35 million debt and equity investment from Crestline Investors to develop new facilities and make an acquisition.
Leading call tracking and attribution technology provider expands C-suite with addition of seasoned marketing executive to support exponential growth.
On the back of record revenues, company expands offices and recruits veteran SaaS sales leader.
OrthAlign, Inc., a privately held U.S.-based medical device company, received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its UniAlign™ system, the world’s first handheld, single-use navigation device for Unicompartmental Knee Arthroplasty (UKA) surgeries.
NICO Corporation, an Indianapolis-based neurosurgery medical device manufacturer, recently completed a $15 million capital raise important to the expansion of newly developed markets created by their technologies and systems approach to subcortical brain surgery.
OrthAlign, Inc., a privately held U.S.-based medical device company, announced today that it has entered into a multi-country distribution agreement with Smith & Nephew, for its award-winning Total Knee Arthroplasty (TKA) technology, KneeAlign®.
NineSigma, the leading innovation partner to companies worldwide, today announces the growth of a new Innovation Gallery sponsored by Natural Resources Canada on NineSights.
Lattice Engines celebrates biggest quarter in its history.
We enjoyed a productive year welcoming several new portfolio companies and celebrating three successful liquidity events.
OrthAlign, Inc., a privately held U.S. based medical device company developing precision technologies, announced today that it exceeded its total 2015 sales forecasts, growing by more than 50% versus 2014. OrthAlign has exceeded sales forecasts for the past three years.